Company / Working Capital
AbbVie Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$14.2B
FY2025
5-year range
-$14.2B / -$1.1B
FY2021-FY2025
Trend
-8.1%
vs FY2024
Sector context
#215 of 215
Health Care
What the data says
Among 215 Health Care companies, AbbVie is in the bottom 0% for working capital. Working Capital has declined for 3 consecutive years, from -$1.1B in FY2022 to -$14.2B in FY2025.
Based on SEC 10-K filings.
-$14.2B in FY2025.
Declined from -$4.8B to -$14.2B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 215This company -$14.2B Sector average $957.8M
▼
-1585.4% below sector average
Key checks
Key Insights
- AbbVie's working capital has declined for 3 consecutive years.
- In FY2025, working capital decreased 8.1% year-over-year.
- Ranks #215 out of 215 companies in the Health Care sector.
- Peak working capital was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$14.2B | -8.1% |
| FY2024 | -$13.2B | -172.1% |
| FY2023 | -$4.8B | -350.1% |
| FY2022 | -$1.1B | +85.2% |
| FY2021 | -$7.3B | -61.9% |
| FY2020 | -$4.5B | -113.2% |
| FY2019 | $33.9B | +11642.2% |
| FY2018 | -$294.0M | -106.4% |
| FY2017 | $4.6B | -28.5% |
| FY2016 | $6.4B | +18.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026